Sepsis biomarkers: a review of the diagnostic value of presepsin

Authors

DOI:

https://doi.org/10.11606/issn.1679-9836.v102i1e-182916

Keywords:

Biomarkers, Sepsis, Diagnosis, Presepsin, Procalcitonin, CRP

Abstract

Sepsis is a prevalent syndrome with high morbimortality, so an efficient early diagnostic method is needed. Recent studies suggest that presepsin could be a potential biomarker to sepsis diagnosis and has a better performance than other more consolidated biomarkers, such as procalcitonin and CRP. This systematic review aims to develop assess the accuracy to sepsis diagnosis of the presepsin and compare with procalcitonin and C-reactive protein. A comprehensive systematic research was conducted in the PubMed and Virtual Health Library to collect studies published in the last two years that focused on presepsin diagnostic accuracy for sepsis. Eight studies were selected. All of them suggested that presepsin has some diagnostic value for sepsis. In four studies presepsin had a better performance than procalcitonin and in two studies presepsin performed better than CRP. Two studies did not show significant differences between presepsin and the other biomarkers. This review indicates that presepsin may have significant value for the early diagnosis of sepsis, corroborating to increase the efficiency of existing tools, such as CRP and procalcitonin. However, more studies are needed to confirm its efficiency as a single diagnosis’s marker.

Downloads

Download data is not yet available.

Author Biographies

  • Thalissa Ferreira, Universidade de São Paulo. Faculdade de Medicina

    Graduating in the medical course at the Faculty of Medicine of the University of São Paulo (FMUSP), has technical training in administration from the Technical Institute of Barueri (ITB) - Professor Munir José (2010-2013)

  • Marcelo Arruda Candido, Universidade de São Paulo. Faculdade de Medicina

    Mechanical technician at the Federal Institute of São Paulo (IFSP, 2017) and majoring in medicine at the Faculty of Medicine of the University of São Paulo (FMUSP).

  • Francisco Garcia Soriano , Universidade de São Paulo. Faculdade de Medicina

    Graduated in Medicine from the Faculty of Medicine of the University of São Paulo (1984) and doctorate in Physiology and Biophysics from the Institute of Biomedical Sciences at USP (1995). He is currently an associate professor at the Faculty of Medicine of the University of São Paulo. He works at FMUSP, Hospital das Clínicas, FMUSP and Hospital Universitário, FMUSP. He has experience in the field of Medicine, with an emphasis on Clinical Emergencies. The central area of research is sepsis.

References

Implementação de Protocolo Gerenciado de Sepse. Protocolo Clínico. Atendimento ao paciente adulto com sepse / choque séptico. Instituto Latino Americano de Sepse; 2018. Disponível em: https://ilas.org.br/wp-content/uploads/2022/02/protocolo-de-tratamento.pdf

Singer M, Deutschman CS, Seymour CW, Shankar-Hari M, Annane D, Bauer M, et al. The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). JAMA. 2016;315(8):801-10. doi: 10.1001/jama.2016.0287

Huang M, Cai S, Su J. The pathogenesis of sepsis and potential therapeutic targets. Int J Mol Sci. 2019;20(21). doi: 10.3390/ijms20215376

Bone RC, Balk RA, Cerra FB, Dellinger RP, Fein AM, Knaus WA, et al. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest. 1992;101(6):1644-55. doi: 10.1378/chest.101.6.1644

Chakraborty R, Burns B. Systemic inflammatory response syndrome. Treasure Island (FL): StatPearls Publishing; 2021 Available from: https://www.ncbi.nlm.nih.gov/books/NBK547669/

Kaukonen KM, Bailey M, Pilcher D, Cooper DJ, Bellomo R. Systemic inflammatory response syndrome criteria in defining severe sepsis. N Engl J Med. 2015;372(17):1629-38. doi: 10.1056/NEJMoa1415236

Churpek MM, Zadravecz FJ, Winslow C, Howell MD, Edelson DP. Incidence and prognostic value of the systemic inflammatory response syndrome and organ dysfunctions in ward patients. Am J Respir Crit Care Med. 2015;192(8):958-64. doi: 10.1164/rccm.201502-0275OC

Seymour CW, Liu VX, Iwashyna TJ, Brunkhorst FM, Rea TD, Scherag A, et al. Assessment of Clinical Criteria for Sepsis: For the Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). JAMA. 2016;315(8):762-74. doi: 10.1001/jama.2016.0288

Jaramillo-Bustamante JC, Piñeres-Olave BE, González-Dambrauskas S. SIRS or not SIRS: Is that the infection? A critical review of the sepsis definition criteria. Bol Med Hosp Infant Mex. 2020;77(6):293-302. doi: 10.24875/BMHIM.20000202

Besen B, Romano TG, Nassar AP, Jr., Taniguchi LU, Azevedo LCP, Mendes PV, et al. Sepsis-3 definitions predict ICU mortality in a low-middle-income country. Ann Intens Care. 2016;6(1):107. doi: 10.1186/s13613-016-0204-y

Machado FR, Assunção MSCd, Cavalcanti AB, Japiassú AM, Azevedo LCPd, Oliveira MC. Chegando a um consenso: vantagens e desvantagens do Sepsis 3 considerando países de recursos limitados. Rev Bras Ter Intens. 2016;28:361-5. doi: 10.5935/0103-507X.20160068

Rhee C, Jones TM, Hamad Y, Pande A, Varon J, O’Brien C, et al. Prevalence, underlying causes, and preventability of sepsis-associated mortality in US acute care hospitals. JAMA Netw Open. 2019;2(2):e187571. doi: 10.1001/jamanetworkopen.2018.7571

Caterino JM, Stevenson KB. Disagreement between emergency physician and inpatient physician diagnosis of infection in older adults admitted from the Emergency Department. Acad Emerg Med. 2012;19(8):908-15. doi: 10.1111/j.1553-2712.2012.01415.x

Raveendran AV, Kumar A, Gangadharan S. Biomarkers and newer laboratory investigations in the diagnosis of sepsis. J R Coll Physicians Edinb. 2019;49(3):207-16. doi: 10.4997/JRCPE.2019.308

Chenevier-Gobeaux C, Trabattoni E, Roelens M, Borderie D, Claessens YE. Presepsin (sCD14-ST) in emergency department: the need for adapted threshold values? Clin Chim Acta. 2014;427:34-6. doi: 10.1016/j.cca.2013.09.019

Takahashi G, Shibata S, Ishikura H, Miura M, Fukui Y, Inoue Y, et al. Presepsin in the prognosis of infectious diseases and diagnosis of infectious disseminated intravascular coagulation: a prospective, multicentre, observational study. Eur J Anaesthesiol. 2015;32(3):199-206. doi: 10.1097/EJA.0000000000000178

Wu CC, Lan HM, Han ST, Chaou CH, Yeh CF, Liu SH, et al. Comparison of diagnostic accuracy in sepsis between presepsin, procalcitonin, and C-reactive protein: a systematic review and meta-analysis. Ann Intensive Care. 2017;7(1):91. doi: 10.1186/s13613-017-0316-z

Parri N, Trippella G, Lisi C, De Martino M, Galli L, Chiappini E. Accuracy of presepsin in neonatal sepsis: systematic review and meta-analysis. Expert Rev Anti Infect Ther. 2019;17(4):223-32. doi: 10.1080/14787210.2019.1584037

Piccioni A, Santoro MC, de Cunzo T, Tullo G, Cicchinelli S, Saviano A, et al. Presepsin as Early Marker of Sepsis in Emergency Department: a narrative review. Medicina (Kaunas). 2021;57(8). doi: 10.3390/medicina57080770

Zhao J, Tan Y, Wang L, Shi Y. Discriminatory ability and prognostic evaluation of presepsin for sepsis-related acute respiratory distress syndrome. Scientific Rep. 2020;10(1):9114-. doi: 10.1038/s41598-020-66121-7

Imai Y, Taniguchi K, Iida R, Nitta M, Uchiyma K, Takasu A. Diagnostic accuracy of presepsin in predicting bacteraemia in elderly patients admitted to the emergency department: prospective study in Japan. BMJ open. 2019;9(12):e030421-e. doi: 10.1136/bmjopen-2019-030421

Venugopalan DP, Pillai G, Krishnan S. Diagnostic Value and Prognostic Use of Presepsin Versus Procalcitonin in Sepsis. Cureus. 2019;11(7):e5151-e. doi: 10.7759/cureus.5151

Brodska H, Valenta J, Pelinkova K, Stach Z, Sachl R, Balik M, et al. Diagnostic and prognostic value of presepsin vs. established biomarkers in critically ill patients with sepsis or systemic inflammatory response syndrome. Clin Chem Lab Med. 2018;56(4):658. doi: 10.1515/cclm-2017-0839

Lu B, Zhang Y, Li C, Liu C, Yao Y, Su M, et al. The utility of presepsin in diagnosis and risk stratification for the emergency patients with sepsis. Am J Emerg Med. 2018;36(8):1341-5. doi: 10.1016/j.ajem.2017.12.038

Tambo M, Taguchi S, Nakamura Y, Okegawa T, Fukuhara H. Presepsin and procalcitonin as predictors of sepsis based on the new Sepsis-3 definitions in obstructive acute pyelonephritis. BMC Urol. 2020;20(1):23. doi: 10.1186/s12894-020-00596-4

Yamamoto T, Nishimura T, Kaga S, Uchida K, Tachibana Y, Esaki M, et al. Diagnostic accuracy of presepsin for sepsis by the new Sepsis-3 definitions. Am J Emerg Med. 2019;37(10):1936-41. doi: 10.1016/j.ajem.2019.01.025

Nakamura Y, Hoshino K, Kiyomi F, Kawano Y, Mizunuma M, Tanaka J, et al. Comparison of accuracy of presepsin and procalcitonin concentrations in diagnosing sepsis in patients with and without acute kidney injury. Clin Chimica Acta. 2019;490:200-6. doi: 10.1016/j.cca.2018.09.013

Douglas IS. New diagnostic methods for pneumonia in the ICU. Curr Opin Infect Dis. 2016;29(2):197-204. doi: 10.1097/QCO.0000000000000249

Kondo Y, Umemura Y, Hayashida K, Hara Y, Aihara M, Yamakawa K. Diagnostic value of procalcitonin and presepsin for sepsis in critically ill adult patients: a systematic review and meta-analysis. J Intensive Care. 2019;7(1):22. doi: 10.1186/s40560-019-0374-4

Zhang J, Hu Z-D, Song J, Shao J. Diagnostic value of presepsin for sepsis: a systematic review and meta-analysis. Medicine. 2015;94(47):e2158-e. doi: 10.1097/MD.0000000000002158

Downloads

Published

2023-03-06

Issue

Section

Artigos de Revisão/Review Articles

How to Cite

Ferreira, T., Candido, M. A. ., & Soriano , F. G. . (2023). Sepsis biomarkers: a review of the diagnostic value of presepsin. Revista De Medicina, 102(1), e-182916. https://doi.org/10.11606/issn.1679-9836.v102i1e-182916